These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 27889726)

  • 1. Prolonged Infusion of Dexmedetomidine in Critically-ill Children.
    Andreolio C; Piva JP; Baldasso E; Ferlini R; Piccoli R
    Indian Pediatr; 2016 Nov; 53(11):987-989. PubMed ID: 27889726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of prolonged dexmedetomidine use in critically ill children with heart disease*.
    Gupta P; Whiteside W; Sabati A; Tesoro TM; Gossett JM; Tobias JD; Roth SJ
    Pediatr Crit Care Med; 2012 Nov; 13(6):660-6. PubMed ID: 22791093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular Effects of Continuous Dexmedetomidine Infusion Without a Loading Dose in the Pediatric Intensive Care Unit.
    Cummings BM; Cowl AS; Yager PH; El Saleeby CM; Shank ES; Noviski N
    J Intensive Care Med; 2015 Dec; 30(8):512-7. PubMed ID: 24923492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of dexmedetomidine in children after cardiac and thoracic surgery.
    Chrysostomou C; Di Filippo S; Manrique AM; Schmitt CG; Orr RA; Casta A; Suchoza E; Janosky J; Davis PJ; Munoz R
    Pediatr Crit Care Med; 2006 Mar; 7(2):126-31. PubMed ID: 16446599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of dexmedetomidine in the pediatric intensive care unit.
    Buck ML; Willson DF
    Pharmacotherapy; 2008 Jan; 28(1):51-7. PubMed ID: 18154474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexmedetomidine Use in a Pediatric Intensive Care Unit: A Retrospective Cohort Study.
    Banasch HL; Dersch-Mills DA; Boulter LL; Gilfoyle E
    Ann Pharmacother; 2018 Feb; 52(2):133-139. PubMed ID: 28952341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexmedetomidine as Single Continuous Sedative During Noninvasive Ventilation: Typical Usage, Hemodynamic Effects, and Withdrawal.
    Shutes BL; Gee SW; Sargel CL; Fink KA; Tobias JD
    Pediatr Crit Care Med; 2018 Apr; 19(4):287-297. PubMed ID: 29341985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexmedetomidine use in a pediatric cardiac intensive care unit: can we use it in infants after cardiac surgery?
    Chrysostomou C; Sanchez De Toledo J; Avolio T; Motoa MV; Berry D; Morell VO; Orr R; Munoz R
    Pediatr Crit Care Med; 2009 Nov; 10(6):654-60. PubMed ID: 19295456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term dexmedetomidine use and safety profile among critically ill children and neonates.
    Whalen LD; Di Gennaro JL; Irby GA; Yanay O; Zimmerman JJ
    Pediatr Crit Care Med; 2014 Oct; 15(8):706-14. PubMed ID: 25068249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged sedation in critically ill children: is dexmedetomidine a safe option for younger age? An off-label experience.
    Sperotto F; Mondardini MC; Vitale F; Daverio M; Campagnano E; Ferrero F; Rossetti E; Vasile B; Dusio MP; Ferrario S; Savron F; Brugnaro L; Amigoni A;
    Minerva Anestesiol; 2019 Feb; 85(2):164-172. PubMed ID: 30394067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the use of dexmedetomidine in neurocritical care patients.
    Grof TM; Bledsoe KA
    Neurocrit Care; 2010 Jun; 12(3):356-61. PubMed ID: 20217277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of dexmedetomidine in facilitating extubation in the intensive care unit.
    Arpino PA; Kalafatas K; Thompson BT
    J Clin Pharm Ther; 2008 Feb; 33(1):25-30. PubMed ID: 18211613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of dexmedetomidine on agitation during weaning of mechanical ventilation in critically ill patients.
    Shehabi Y; Nakae H; Hammond N; Bass F; Nicholson L; Chen J
    Anaesth Intensive Care; 2010 Jan; 38(1):82-90. PubMed ID: 20191782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of dexmedetomidine therapy on the management of severe alcohol withdrawal syndrome in critically ill patients.
    Frazee EN; Personett HA; Leung JG; Nelson S; Dierkhising RA; Bauer PR
    J Crit Care; 2014 Apr; 29(2):298-302. PubMed ID: 24360597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic effects of dexmedetomidine in critically ill neonates and infants with heart disease.
    Lam F; Bhutta AT; Tobias JD; Gossett JM; Morales L; Gupta P
    Pediatr Cardiol; 2012 Oct; 33(7):1069-77. PubMed ID: 22327182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged use of dexmedetomidine in the paediatric cardiothoracic intensive care unit.
    Bejian S; Valasek C; Nigro JJ; Cleveland DC; Willis BC
    Cardiol Young; 2009 Feb; 19(1):98-104. PubMed ID: 19154626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase II study to evaluate the efficacy of dexmedetomidine for sedation in the medical intensive care unit.
    Venn M; Newman J; Grounds M
    Intensive Care Med; 2003 Feb; 29(2):201-7. PubMed ID: 12594584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged infusions of dexmedetomidine in critically ill patients.
    Guinter JR; Kristeller JL
    Am J Health Syst Pharm; 2010 Aug; 67(15):1246-53. PubMed ID: 20651314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of dexmedetomidine in critically ill children.
    Czaja AS; Zimmerman JJ
    Pediatr Crit Care Med; 2009 May; 10(3):381-6. PubMed ID: 19325505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcutaneous dexmedetomidine infusions to treat or prevent drug withdrawal in infants and children.
    Tobias JD
    J Opioid Manag; 2008; 4(4):187-91. PubMed ID: 18837201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.